EFFECT OF PGI2 ON PLATELET BINDING TO PARTIALLY DENUDED ENDOTHELIAL MONOLAYER INVITRO

被引:3
作者
YAGYU, Y
HASHIDA, R
IWASAKI, K
MINEO, C
IMANAKA, T
TAKANO, T
机构
[1] Department of Microbiology and Molecular Pathology, Faculty of Pharmaceutical Sciences, Teikyo University, Sagamiko, Kanagawa
关键词
PLATELET ADHESION; AGGREGATION; PROSTACYCLIN; COLLAGEN; FIBRINOGEN; FIBRONECTIN;
D O I
10.1016/0049-3848(91)90073-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have developed a new model for the investigation of platelet interaction with injured vascular endothelium. This involves the quantitative detection of platelet binding to a partially denuded endothelial cell monolayer in vitro. Porcine arterial endothelial monolayer, cultured on collagen gel containing fibrinogen and fibronectin, was partially denuded and the binding of Cr-51-platelets was measured. A synergistic increase in platelet binding was observed in the presence of fibrinogen and fibronectin. A distinct aggregation of platelets along the edge of the denuded area of the endothelial monolayer was seen. Prostacyclin (PGI2) inhibited platelet aggregation, although adhesive platelets were still present at denuded sites.
引用
收藏
页码:733 / 744
页数:12
相关论文
共 35 条
[31]   SYNTHESIS OF 9(O)-METHANO-DELTA-6(9-ALPHA)-PGI1 - THE HIGHLY POTENT CARBON ANALOG OF PROSTACYCLIN [J].
SHIBASAKI, M ;
TORISAWA, Y ;
IKEGAMI, S .
TETRAHEDRON LETTERS, 1983, 24 (33) :3493-3496
[32]   LAMININ RECEPTOR ON PLATELETS IS THE INTEGRIN VLA-6 [J].
SONNENBERG, A ;
MODDERMAN, PW ;
HOGERVORST, F .
NATURE, 1988, 336 (6198) :487-489
[33]   ROLE OF HYDROGEN-PEROXIDE IN NEUTROPHIL-MEDIATED DESTRUCTION OF CULTURED ENDOTHELIAL-CELLS [J].
WEISS, SJ ;
YOUNG, J ;
LOBUGLIO, AF ;
SLIVKA, A ;
NIMEH, NF .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (03) :714-721
[34]   COMPARISON OF EFFECTS OF PROSTACYCLIN (PGI2), PROSTAGLANDIN-E1 AND D2 ON PLATELET-AGGREGATION IN DIFFERENT SPECIES [J].
WHITTLE, BJR ;
MONCADA, S ;
VANE, JR .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1978, 16 (03) :373-388
[35]  
YAGYU YM, 1987, BIOCHEM PHARMACOL, V36, P3809